Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

ADALIMUMAB-AQVH

FDA · BLA · 2026-09-25

AgencyFDA
Submission typeBLA
Action date2026-09-25
BrandYUSIMRY
SponsorEMERGE BIOSCIENCE PTE LTD
RouteINJECTION

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:35:51.650Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:ADALIMUMAB-AQVH:2026-09-25

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

ADALIMUMAB-AQVH — approval | AEaH